Blood test helps spot stroke in sudden severe dizziness

Credibility

Interest

Key Takeaway

Two blood tests (pNfL and pGFAP) may help doctors tell if sudden severe dizziness is caused by a stroke in the back of the brain, and one test (pNfL) is especially good at ruling out stroke.

What They Found

Researchers measured two brain-related proteins in the blood of people who came to the emergency room with sudden severe dizziness. People who had a stroke in the back of the brain (posterior circulation stroke) tended to have higher levels of both proteins than people whose dizziness came from other causes. A higher level of pNfL (neurofilament light chain) was linked to stroke and correctly identified most stroke cases (about 84% sensitivity) while giving few false negatives — meaning if the pNfL test was low, it was very likely not a stroke. The pGFAP (a protein from certain brain support cells) was also higher in stroke, but it missed more strokes than pNfL and was less sensitive (about 58%). Both tests kept their usefulness even when taking into account how long symptoms had been present, and pNfL had a strong ability to rule out stroke when the result was low.

Who Should Care and Why

People with MS and their caregivers should care because sudden severe dizziness can come from many causes, and MS itself or MS-related problems can cause vertigo or balance issues — it can be hard to know when dizziness needs emergency stroke testing. If a simple blood test like pNfL is low, doctors may be more confident that the dizziness is not caused by a stroke, which could reduce unnecessary scans or hospital stays — like using a smoke detector that is good at telling real fires from burnt toast. MS patients who have new or different dizziness, or caregivers who notice sudden changes, may benefit from asking whether such tests are available in their hospital. Clinicians and emergency teams could use these tests to prioritize who needs fast brain imaging, helping patients get the right care more quickly. However, this does not replace a full exam and brain scan when doctors think a stroke is likely — the test is an extra tool, not a complete answer.

Important Considerations

This study was done in a single emergency setting with just over 100 people, so the results might change in other hospitals or larger groups. The tests are helpful but not perfect: pNfL missed some strokes and pGFAP missed more, so doctors still need to use symptoms and scans when needed. Also, levels of these proteins can be affected by other brain injury or conditions, so a high result doesn’t always mean stroke and must be interpreted by a clinician.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Specific Symptoms Early Research

Article Topics:

Blood biomarkerGlial acidic fibrillary proteinNeurofilament light chainStrokeVertigo

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News